Xencor and Gilead entered license agreement for use of XmAb antibody technologies in investigational agents for HIV
On Jan. 8, 2020, Xencor announced a technology license agreement in which Gilead Sciences will access Xencor’s Xtend…
On Jan. 8, 2020, Xencor announced a technology license agreement in which Gilead Sciences will access Xencor’s Xtend…
On Jan. 8, 2020, the U.S. Food and Drug Administration (FDA) approved patient-specific airway stents developed by Cleveland…
On Jan. 7, 2020, the Fred Hutchinson Cancer Research Center announced Dr. Thomas J. Lynch Jr. as the…
On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…
On Dec. 20, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Daiichi Sankyo’s Enhertu…
On Dec. 20, 2019, Dr. Pedro Rosa-Neto announced the discovery that the protein APOEꜫ4 plays a central role…
On Dec. 18, 2019, the Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy…
On Dec. 18, 2019, Seagen and Astellas Pharma announced the U.S. Food and Drug Administration (FDA) had granted…
On Dec. 17, 2019, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) announced that Gregory Friedman,…
On Dec. 12, 2019, BioAegis Therapeutics announced publication of new research findings with recombinant human plasma gelsolin in…
On Dec. 12, 2019, Vanderbilt University Medical Center (VUMC) researchers James Crowe Jr., MD, and colleagues announced they…
On Dec. 11, 2019, Dennis Eggers became the first patient in a new clinical trial to receive a…
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
On Dec. 4. 2019, US-based Nanomix announced that the company had received CE Mark for its S1 Assay…
On Dec. 3, 2019, the Cold Spring Harbor Laboratory researchers with colleagues at UConn Health and Jackson Laboratory…
On Dec. 2, 2019, the U.S. Food and Drug Administration (FDA) announced it had approved the drug crizanlizumab…
On Nov. 24, 2019, Abu Dhabi Health Services Company, the largest healthcare network in the United Arab Emirates…
On Nov. 20, 2019, scientists in Maho Niwa’s lab at the University of California San Diego have provided…
On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the recruitment of its…
On Nov. 20, 2019, Bristol-Myers announced that it had completed its acquisition of Celgene following the receipt of…
On Nov. 19, 2019, Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of…
On Nov. 15, 2019, Amgen in collaboration with the Duke Clinical Research Institute (DCRI) announced plans to initiate…
On Nov. 13, 2019, researchers at University of California San Diego (UCSD) School of Medicine announced that they…
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
On Nov. 7, 2019, the Vanderbilt-Ingram Cancer Center (VICC) announced it is one of three institutions launching the…
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
On Nov. 4, 2019, the University of Utah announced a commitment of $150 million from the Huntsman family…
On Oct. 30, 2019, researchers at the University of Georgia’s Center for the Ecology of Infectious Diseases received…
On Oct. 30, 2019, philanthropist Jay Alix extended his generosity with an additional $15 million endowed gift to…
On Oct. 26, 2019, the Smilow Cancer Hospital celebrated 10 years since it opened its doors to a…